Literature DB >> 11281212

A genome-wide family-based linkage study of coeliac disease.

A L King1, J Y Yiannakou, P M Brett, D Curtis, M A Morris, A M Dearlove, M Rhodes, S Rosen-Bronson, C Mathew, H J Ellis, P J Ciclitira.   

Abstract

The susceptibility to develop coeliac disease (CD) has a strong genetic component, which is not entirely explained by HLA associations. Two previous genome wide linkage studies have been performed to identify additional loci outside this region. These studies both used a sib-pair design and produced conflicting results. Our aim is to identify non-MHC genetic loci contributing to coeliac disease using a family based linkage study. We performed a genome wide search in 16 highly informative multiply affected pedigrees using 400 microsatellite markers with an average spacing of 10 cM. Linkage analysis was performed using lod score and model free methods. We identified two new potential susceptibility loci with lod scores of 1.9, at 10q23.1, and 16q23.3. Significant, but lower lod scores were found for 6q14 (1.2), 11p11 (1.5), and 19q13.4 (0.9), areas implicated in a previous genome wide study. Lod scores of 0.9 were obtained for both D78507, which lies 1 cM from the gammaT-cell receptor gene, and for D2S364, which lies 12 cM from the CTLA4 gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11281212     DOI: 10.1046/j.1469-1809.2000.6460479.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  9 in total

1.  Genomewide linkage analysis of celiac disease in Finnish families.

Authors:  Jianjun Liu; Suh-Hang Juo; Päivi Holopainen; Joseph Terwilliger; Xiaomei Tong; Adina Grunn; Miguel Brito; Peter Green; Kirsi Mustalahti; Markku Mäki; T Conrad Gilliam; Jukka Partanen
Journal:  Am J Hum Genet       Date:  2001-11-19       Impact factor: 11.025

Review 2.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 3.  Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Authors:  Frits Koning; Luud Gilissen; Cisca Wijmenga
Journal:  Springer Semin Immunopathol       Date:  2005-08-10

4.  Meta-analysis of genome-wide linkage studies in celiac disease.

Authors:  Paola Forabosco; Susan L Neuhausen; Luigi Greco; Asa Torinsson Naluai; Cisca Wijmenga; Paivi Saavalainen; Richard S Houlston; Paul J Ciclitira; Marie-Claude Babron; Cathryn M Lewis
Journal:  Hum Hered       Date:  2009-07-22       Impact factor: 0.444

5.  Celiac disease and HLA in a Bedouin kindred.

Authors:  Elise Eller; Pnina Vardi; Sunanda R Babu; Teodorica L Bugawan; Henry A Erlich; Liping Yu; Pamela R Fain
Journal:  Hum Immunol       Date:  2006-09-18       Impact factor: 2.850

6.  The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.

Authors:  Martin Storr; Dominik Emmerdinger; Julia Diegelmann; Simone Pfennig; Thomas Ochsenkühn; Burkhard Göke; Peter Lohse; Stephan Brand
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

7.  Association of FAS (TNFRSF6)-670 gene polymorphism with villous atrophy in coeliac disease.

Authors:  Jing Wu; B Z Alizadeh; T V Veen; J W R Meijer; C J J Mulder; A S Pena
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study.

Authors:  S L Neuhausen; M Feolo; J Farnham; L Book; J J Zone
Journal:  BMC Med Genet       Date:  2001-11-30       Impact factor: 2.103

9.  Exome sequencing of 75 individuals from multiply affected coeliac families and large scale resequencing follow up.

Authors:  Vanisha Mistry; Nicholas A Bockett; Adam P Levine; Muddassar M Mirza; Karen A Hunt; Paul J Ciclitira; Holger Hummerich; Susan L Neuhausen; Michael A Simpson; Vincent Plagnol; David A van Heel
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.